Compare BSX & MRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | MRSH |
|---|---|---|
| Founded | 1979 | 1871 |
| Country | United States | United States |
| Employees | N/A | 55700 |
| Industry | Medical/Dental Instruments | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 84.3B |
| IPO Year | 2010 | N/A |
| Metric | BSX | MRSH |
|---|---|---|
| Price | $42.84 | $167.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 22 | 11 |
| Target Price | $93.18 | ★ $199.27 |
| AVG Volume (30 Days) | ★ 19.6M | 2.5M |
| Earning Date | 04-22-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $9,076,000,000.00 | N/A |
| Revenue This Year | $11.85 | $6.85 |
| Revenue Next Year | $10.16 | $4.70 |
| P/E Ratio | $48.31 | ★ $21.13 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $43.37 | $156.60 |
| 52 Week High | $109.50 | $193.32 |
| Indicator | BSX | MRSH |
|---|---|---|
| Relative Strength Index (RSI) | 25.41 | 53.70 |
| Support Level | N/A | $164.97 |
| Resistance Level | $50.14 | $169.66 |
| Average True Range (ATR) | 1.41 | 3.71 |
| MACD | 0.05 | 0.47 |
| Stochastic Oscillator | 10.87 | 73.01 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.